About NuView Life Sciences
NuView Life Sciences is a company based in Park City (United States) founded in 2005. NuView Life Sciences has raised $90 million across 3 funding rounds from investors including HHS and Global Emerging Markets. NuView Life Sciences offers products and services including NV-VPAC1, In Vitro Diagnostic Kit, and PET Imaging Agent. NuView Life Sciences operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Park City, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nuview Life Sciences, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$90 M (USD)
in 3 rounds
-
Latest Funding Round
$90 M (USD), Private Equity Round
Aug 03, 2020
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NuView Life Sciences
NuView Life Sciences offers a comprehensive portfolio of products and services, including NV-VPAC1, In Vitro Diagnostic Kit, and PET Imaging Agent.
Proprietary molecule for cancer imaging and targeted therapy applications.
Detects cancer cells in biofluids without invasive procedures.
Uses Copper-64 for in vivo cancer diagnosis and localization.
People of NuView Life Sciences
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of NuView Life Sciences
NuView Life Sciences has successfully raised a total of $90M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round of $90 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NuView Life Sciences
NuView Life Sciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Global Emerging Markets.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for NuView Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NuView Life Sciences
Investment portfolio details for NuView Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NuView Life Sciences
Detailed financials for NuView Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nuview Life Sciences Comparisons
Peer comparison for NuView Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NuView Life Sciences
NuView Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of NuView Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nuview Life Sciences
Complete news archive for NuView Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NuView Life Sciences
NuView Life Sciences was founded in 2005 and raised its 1st funding round 6 years after it was founded.
NuView Life Sciences is headquartered in Park City, United States. It is registered at Park City, Utah, United States.
Paul Crowe is the current CEO of NuView Life Sciences.
NuView Life Sciences is a funded company, having raised a total of $90M across 3 funding rounds to date.
NuView Life Sciences was founded in 2005 and is based in Park City, United States. Operations focus on the biotechnology sector, where a diagnostic device known as NV-VPAC1 is developed. This device utilizes peptide analogs to target the vasoactive intestinal peptide receptor type 1 (VPAC1), which is overexpressed in malignancies including breast, prostate, colon, bladder, and endometrial cancers. Diagnostic services for these conditions are thereby supported.
NuView Life Sciences's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
NuView Life Sciences offers NV-VPAC1, In Vitro Diagnostic Kit, and PET Imaging Agent.
NuView Life Sciences has 2 investors. Key investors include HHS, and Global Emerging Markets.